{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:02:28Z","timestamp":1790787748024,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Insights Imaging"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To analyze revision rates after transjugular intrahepatic portosystemic shunt (TIPS) using expanded polytetrafluoroethylene-covered stentgrafts and to identify predictors of shunt revisions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This single-center retrospective study included 514 consecutive patients (mean age 56.9\u2009\u00b1\u200912.7 years; 194 females) with TIPS placement between 2003 and 2021. Follow-up included clinical assessment, laboratory testing, ultrasound, and computed tomography. Reinterventions were categorized by type and technique. Univariable and multivariable Cox regression analyses were performed to identify predictors of shunt dilation and reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 149 patients (28.9%) required TIPS revision: 95 (18.5%) shunt dilation, 42 (8.2%) shunt reduction, and 12 (2.3%) others. Median time to first revision was 2.8 months (3.2 months for dilation, 1.9 months for reduction). Indications for first shunt dilation were persistent or recurrent refractory ascites (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200961), recurrent variceal bleeding (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097), and asymptomatic stenosis or occlusion of the TIPS tract (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927). Indications for shunt reduction were hepatic encephalopathy refractory to conservative measures (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200939) and acute liver failure following TIPS (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093). Forty-seven patients (9.1%) underwent two or more reinterventions. Multivariable Cox analysis identified immediate post-TIPS portosystemic pressure gradients &gt; 8\u2009mmHg, prior hepatic encephalopathy, and hepatorenal syndrome prior to TIPS as predictors of mandatory shunt dilation. In contrast, age \u2265 65 years, female gender, serum sodium levels, and a pre-TIPS hepatic hydrothorax were predictive of shunt reduction during revision.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Around one in three patients requires shunt revision. Predictive factors for revision varied by intervention type: shunt dilation was linked to disease severity and portal pressure, whereas reduction was more closely related to the patient\u2019s age and gender.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Critical relevance statement<\/jats:title>\n                    <jats:p>Patients who undergo TIPS require structured, long-term follow-up to identify clinical situations that may necessitate shunt adaptation or other secondary interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Points<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Shunt revision after TIPS occurs in one-third of patients, with prognostic significance.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Several independent prognostic factors for both shunt dilation and reduction were identified.<\/jats:p>\n                        <\/jats:list-item>\n                        <jats:list-item>\n                          <jats:p>Structured long-term follow-up is crucial to identify patients needing shunt revision.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13244-025-02122-2","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T13:31:32Z","timestamp":1762349492000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Transjugular intrahepatic portosystemic shunt with ePTFE-covered stentgrafts: incidence and predictors of shunt dysfunction"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5572-7763","authenticated-orcid":false,"given":"Michael B.","family":"Pitton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Stoehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Weinmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Labenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Kloeckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"D\u00fcber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Otto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"2122_CR1","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1478-3231.2007.01522.x","volume":"27","author":"C Bureau","year":"2007","unstructured":"Bureau C, Garcia Pagan JC, Layrargues GP et al (2007) Patency of stents covered with polytetrafluoroethylene in patients treated by transjugular intrahepatic portosystemic shunts: long-term results of a randomized multicentre study. Liver Int 27:742\u2013747","journal-title":"Liver Int"},{"key":"2122_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2021.100264","volume":"3","author":"M Praktiknjo","year":"2021","unstructured":"Praktiknjo M, Abu-Omar J, Chang J et al (2021) Controlled underdilation using novel VIATORR\u00ae controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep 3:100264","journal-title":"JHEP Rep"},{"key":"2122_CR3","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1007\/s00261-022-03685-0","volume":"47","author":"G Mamone","year":"2022","unstructured":"Mamone G, Milazzo M, Di Piazza A et al (2022) Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know. Abdom Radiol (NY) 47:4254\u20134270","journal-title":"Abdom Radiol (NY)"},{"key":"2122_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2021.109986","volume":"144","author":"RK Patel","year":"2021","unstructured":"Patel RK, Chandel K, Tripathy TP, Mukund A (2021) Complications of transjugular intrahepatic portosystemic shunt (TIPS) in the era of the stent graft\u2014what the interventionists need to know? Eur J Radiol 144:109986","journal-title":"Eur J Radiol"},{"key":"2122_CR5","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1055\/s-0038-1676092","volume":"35","author":"AW Darrow","year":"2018","unstructured":"Darrow AW, Gaba RC, Lokken RP (2018) Transhepatic revision of occluded transjugular intrahepatic portosystemic shunt complicated by endotipsitis. Semin Interv Radiol 35:492\u2013496","journal-title":"Semin Interv Radiol"},{"key":"2122_CR6","first-page":"62","volume":"2","author":"P Gupta","year":"2016","unstructured":"Gupta P, Donahue TR (2016) Polymicrobial transjugular intrahepatic portosystemic shunt infection in the setting of a prior hepaticojejunostomy anastomosis: a case report. Case Rep Pancreat Cancer 2:62\u201364","journal-title":"Case Rep Pancreat Cancer"},{"key":"2122_CR7","doi-asserted-by":"crossref","unstructured":"Geeroms B, Laleman W, Laenen A et al (2016) Expanded polytetrafluoroethylene-covered stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic patients: long-term patency and clinical outcome results. Eur Radiol 27:1795\u20131803","DOI":"10.1007\/s00330-016-4570-5"},{"key":"2122_CR8","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1136\/gut.2005.089482","volume":"55","author":"N Kochar","year":"2006","unstructured":"Kochar N, Tripathi D, Ireland H, Redhead DN, Hayes PC (2006) Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy. Gut 55:1617\u20131623","journal-title":"Gut"},{"key":"2122_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00270-018-1992-2","volume":"41","author":"MW Rowley","year":"2018","unstructured":"Rowley MW, Choi M, Chen S, Hirsch K, Seetharam AB (2018) Refractory hepatic encephalopathy after elective transjugular intrahepatic portosystemic shunt: risk factors and outcomes with revision. Cardiovasc Interv Radiol 41:1765\u20131772","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR10","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1111\/j.1572-0241.2008.02102.x","volume":"103","author":"O Riggio","year":"2008","unstructured":"Riggio O, Angeloni S, Salvatori FM et al (2008) Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts. Am J Gastroenterol 103:2738\u20132746","journal-title":"Am J Gastroenterol"},{"key":"2122_CR11","doi-asserted-by":"publisher","first-page":"e00378","DOI":"10.14309\/ctg.0000000000000378","volume":"12","author":"S Saab","year":"2021","unstructured":"Saab S, Zhao M, Asokan I, Yum JJ, Lee EW (2021) History of hepatic encephalopathy is not a contraindication to transjugular intrahepatic portosystemic shunt placement for refractory ascites. Clin Transl Gastroenterol 12:e00378","journal-title":"Clin Transl Gastroenterol"},{"key":"2122_CR12","doi-asserted-by":"publisher","first-page":"111303","DOI":"10.1016\/j.jbiomech.2022.111303","volume":"143","author":"K Yin","year":"2022","unstructured":"Yin K, Wang X, Zheng T (2022) Computational hemodynamic analysis for optimal stent position in the transjugular intrahepatic portosystemic shunt procedure. J Biomech 143:111303","journal-title":"J Biomech"},{"key":"2122_CR13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.5152\/tjg.2023.21964","volume":"34","author":"P Bhatia Kapoor","year":"2023","unstructured":"Bhatia Kapoor P, Benjamin J, Tripathi H et al (2023) Post-transjugular intrahepatic portosystemic shunt hepatic encephalopathy: sarcopenia adds insult to injury. Turk J Gastroenterol 34:406\u2013412","journal-title":"Turk J Gastroenterol"},{"key":"2122_CR14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s00270-021-02961-8","volume":"45","author":"W Cai","year":"2022","unstructured":"Cai W, Lin H, Qi R et al (2022) Psoas muscle density predicts occurrences of hepatic encephalopathy in patients receiving transjugular intrahepatic portosystemic shunts within 1 year. Cardiovasc Interv Radiol 45:93\u2013101","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR15","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1111\/liv.15060","volume":"41","author":"S Gioia","year":"2021","unstructured":"Gioia S, Ridola L, Cristofaro L et al (2021) The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt. Liver Int 41:2965\u20132973","journal-title":"Liver Int"},{"key":"2122_CR16","doi-asserted-by":"crossref","unstructured":"Krishnamurthy P, Ahmad A (2021) Successful treatment of recurrent hepatic encephalopathy with revision of transjugular intrahepatic portasystemic shunt and embolisation of splenorenal shunt. BMJ Case Rep 14:e242368","DOI":"10.1136\/bcr-2021-242368"},{"key":"2122_CR17","doi-asserted-by":"crossref","unstructured":"Tang HH, Zhang ZC, Zhao ZL et al (2022) Large paraumbilical vein shunts increase the risk of overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt placement. J Clin Med 12:158","DOI":"10.3390\/jcm12010158"},{"key":"2122_CR18","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1007\/s00261-022-03600-7","volume":"47","author":"W Yao","year":"2022","unstructured":"Yao W, Liu JC, Wu YJ et al (2022) Effect of underdilated transjugular intrahepatic portosystemic shunt on prognosis in patients with prior splenectomy: a propensity score-matched case-control study. Abdom Radiol (NY) 47:3615\u20133627","journal-title":"Abdom Radiol (NY)"},{"key":"2122_CR19","doi-asserted-by":"publisher","first-page":"e00376","DOI":"10.14309\/ctg.0000000000000376","volume":"12","author":"J Liu","year":"2021","unstructured":"Liu J, Ma J, Zhou C et al (2021) Potential benefits of underdilation of 8-mm covered stent in transjugular intrahepatic portosystemic shunt creation. Clin Transl Gastroenterol 12:e00376","journal-title":"Clin Transl Gastroenterol"},{"key":"2122_CR20","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00270-015-1197-x","volume":"39","author":"K Pereira","year":"2016","unstructured":"Pereira K, Carrion AF, Salsamendi J, Doshi M, Baker R, Kably I (2016) Endovascular management of refractory hepatic encephalopathy complication of transjugular intrahepatic portosystemic shunt (TIPS): comprehensive review and clinical practice algorithm. Cardiovasc Interv Radiol 39:170\u2013182","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR21","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.jvir.2022.08.030","volume":"33","author":"J Ronald","year":"2022","unstructured":"Ronald J, Kim CY, Konanur M et al (2022) Coaxial stent graft inside a constraining stent for transjugular intrahepatic portosystemic shunt reduction. J Vasc Inter Radiol 33:1513\u20131518.e1511","journal-title":"J Vasc Inter Radiol"},{"key":"2122_CR22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1056\/NEJM199401203300303","volume":"330","author":"M Rossle","year":"1994","unstructured":"Rossle M, Haag K, Ochs A et al (1994) The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 330:165\u2013171","journal-title":"N Engl J Med"},{"key":"2122_CR23","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.4254\/wjh.v14.i6.1200","volume":"14","author":"N Duong","year":"2022","unstructured":"Duong N, Healey M, Patel K, Strife BJ, Sterling RK (2022) Use of Doppler ultrasound to predict need for transjugular intrahepatic portosystemic shunt revision. World J Hepatol 14:1200\u20131209","journal-title":"World J Hepatol"},{"key":"2122_CR24","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00270-001-0121-8","volume":"25","author":"M Cejna","year":"2002","unstructured":"Cejna M, Peck-Radosavljevic M, Thurnher S et al (2002) ePTFE-covered stent-grafts for revision of obstructed transjugular intrahepatic portosystemic shunt. Cardiovasc Interv Radiol 25:365\u2013372","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR25","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1097\/MEG.0000000000001686","volume":"32","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Zhang W, Zhang Z et al (2020) PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 32:1235\u20131243","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2122_CR26","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/flgastro-2022-102151","volume":"13","author":"D Jeyanesan","year":"2022","unstructured":"Jeyanesan D, Balachandrakumar VK, Hogan B (2022) Guideline review: transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension\u2014a BSG guideline. Frontline Gastroenterol 13:531\u2013534","journal-title":"Frontline Gastroenterol"},{"key":"2122_CR27","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00270-015-1209-x","volume":"39","author":"J Lauermann","year":"2016","unstructured":"Lauermann J, Potthoff A, Mc Cavert M et al (2016) Comparison of technical and clinical outcome of transjugular portosystemic shunt placement between a bare metal stent and a PTFE-stentgraft device. Cardiovasc Interv Radiol 39:547\u2013556","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR28","doi-asserted-by":"crossref","unstructured":"Maruzzelli L, D\u2019Amico M, Tuzzolino F et al (2022) Clinical outcomes of transjugular intrahepatic portosystemic shunt with PTFE-covered stents after liver transplantation and technical results in split and whole liver graft recipients. Eur Radiol 33:2612\u20132619","DOI":"10.1007\/s00330-022-09259-4"},{"key":"2122_CR29","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ueg2.12300","volume":"10","author":"L Weichselbaum","year":"2022","unstructured":"Weichselbaum L, Lepida A, Marot A, Trepo E, Moreno C, Deltenre P (2022) Salvage transjugular intrahepatic portosystemic shunt in patients with cirrhosis and refractory variceal bleeding: a systematic review with meta-analysis. U Eur Gastroenterol J 10:874\u2013887","journal-title":"U Eur Gastroenterol J"},{"key":"2122_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9150173","volume":"2020","author":"SL Chen","year":"2020","unstructured":"Chen SL, Xiao CJ, Wang S, Jin SY, Zhao JB (2020) The pull-through technique for recanalization of transjugular intrahepatic portosystemic shunt dysfunction. Gastroenterol Res Pract 2020:9150173","journal-title":"Gastroenterol Res Pract"},{"key":"2122_CR31","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00270-018-1887-2","volume":"41","author":"S Spiliopoulos","year":"2018","unstructured":"Spiliopoulos S, Vasiniotis Kamarinos N, Konstantos C et al (2018) Recanalization of occluded transjugular intrahepatic portosystemic shunts using the Rosch-Uchida stiffening cannula. Cardiovasc Interv Radiol 41:799\u2013803","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR32","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1016\/j.radcr.2022.04.025","volume":"17","author":"A Ghosh","year":"2022","unstructured":"Ghosh A, Seyoum N, Anand S, Akhter N (2022) Percutaneous CT-guided superior mesenteric vein access for portal vein recanalization-transjugular intrahepatic portosystemic shunt. Radiol Case Rep 17:2603\u20132606","journal-title":"Radiol Case Rep"},{"key":"2122_CR33","doi-asserted-by":"publisher","first-page":"318","DOI":"10.5152\/dir.2017.16238","volume":"23","author":"N Hilliard","year":"2017","unstructured":"Hilliard N, See TC, Shaida N (2017) Ultrasound-assisted thrombolysis of an occluded transjugular portosystemic shunt. Diagn Inter Radiol 23:318\u2013320","journal-title":"Diagn Inter Radiol"},{"key":"2122_CR34","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1053\/j.tvir.2016.01.005","volume":"19","author":"MR Chamarthy","year":"2016","unstructured":"Chamarthy MR, Anderson ME, Pillai AK, Kalva SP (2016) Thrombolysis and transjugular intrahepatic portosystemic shunt creation for acute and subacute portal vein thrombosis. Tech Vasc Inter Radiol 19:42\u201351","journal-title":"Tech Vasc Inter Radiol"},{"key":"2122_CR35","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00270-017-1646-9","volume":"40","author":"A Mahmoud","year":"2017","unstructured":"Mahmoud A, Tabriz DM, Toskich BB (2017) Laser recanalization of a chronically occluded transjugular intrahepatic portosystemic shunt (TIPS). Cardiovasc Interv Radiol 40:1473\u20131476","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR36","doi-asserted-by":"publisher","first-page":"e29742","DOI":"10.1097\/MD.0000000000029742","volume":"101","author":"P Jiao","year":"2022","unstructured":"Jiao P, Chen XY, Zheng HY, Qin J, Li C, Zhang XL (2022) Anticoagulation after transjugular intrahepatic portosystemic shunt for portal hypertension: a systematic review and meta analysis. Medicine (Baltimore) 101:e29742","journal-title":"Medicine (Baltimore)"},{"key":"2122_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14388-3","volume":"12","author":"H Goessmann","year":"2022","unstructured":"Goessmann H, Schuffenhauer V, Kandulski A et al (2022) Retrospective evaluation of early thrombosis in transjugular intrahepatic portosystemic polytetrafluoroethylene-coated shunts under 2-day postinterventional heparinization. Sci Rep 12:10506","journal-title":"Sci Rep"},{"key":"2122_CR38","volume":"10","author":"J Matteo","year":"2018","unstructured":"Matteo J, Caci D, Soule E, Cunningham J, Hood P (2018) Precision onion skinning technique for transjugular intrahepatic portosystemic shunt revision. Cureus 10:e3180","journal-title":"Cureus"},{"key":"2122_CR39","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00270-021-03003-z","volume":"45","author":"MB Pitton","year":"2022","unstructured":"Pitton MB, Weinmann A, Kloeckner R et al (2022) Transjugular portosystemic stent shunt: impact of right atrial pressure on portal venous hemodynamics within the first week. Cardiovasc Interv Radiol 45:102\u2013111","journal-title":"Cardiovasc Interv Radiol"},{"key":"2122_CR40","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1097\/MEG.0000000000002009","volume":"33","author":"MB Pitton","year":"2021","unstructured":"Pitton MB, Zimmermann T, Mildenberger P et al (2021) Decision making for transjugular intrahepatic portosystemic stent shunt in refractory ascites and variceal bleeding: MELD, or not MELD, that is the question. Eur J Gastroenterol Hepatol 33:e214\u2013e222","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2122_CR41","doi-asserted-by":"crossref","unstructured":"Ma L, Ma J, Zhang W et al (2022) Predictive power of portal pressure gradient remeasured shortly after transjugular intrahepatic portosystemic shunt. Hepatol Int 17:417\u2013426","DOI":"10.1007\/s12072-022-10440-6"},{"key":"2122_CR42","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/j.ejrad.2011.06.037","volume":"81","author":"CM Sommer","year":"2012","unstructured":"Sommer CM, Gockner TL, Stampfl U et al (2012) Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus Viatorr stent-grafts (VSG). Eur J Radiol 81:2273\u20132280","journal-title":"Eur J Radiol"},{"key":"2122_CR43","doi-asserted-by":"publisher","first-page":"e0217442","DOI":"10.1371\/journal.pone.0217442","volume":"14","author":"AS Allegretti","year":"2019","unstructured":"Allegretti AS, Frenk NE, Li DK et al (2019) Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS One 14:e0217442","journal-title":"PLoS One"},{"key":"2122_CR44","doi-asserted-by":"publisher","first-page":"e0189414","DOI":"10.1371\/journal.pone.0189414","volume":"13","author":"T Bucsics","year":"2018","unstructured":"Bucsics T, Schoder M, Diermayr M et al (2018) Transjugular intrahepatic portosystemic shunts (TIPS) for the prevention of variceal re-bleeding\u2014a two decades experience. PLoS One 13:e0189414","journal-title":"PLoS One"},{"key":"2122_CR45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13244-024-01768-8","volume":"15","author":"L B\u00fcttner","year":"2024","unstructured":"B\u00fcttner L, Pick L, Jonczyk M et al (2024) Shunt dysfunction and mortality after transjugular intrahepatic portosystemic shunt (TIPS) in patients with portal hypertension. Insights Imaging 15:193","journal-title":"Insights Imaging"},{"key":"2122_CR46","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1001\/jama.2020.9151","volume":"325","author":"K Yadav","year":"2021","unstructured":"Yadav K, Lewis RJ (2021) Immortal time bias in observational studies. JAMA 325:686\u2013687","journal-title":"JAMA"}],"container-title":["Insights into Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02122-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13244-025-02122-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13244-025-02122-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:04:42Z","timestamp":1762351482000},"score":1,"resource":{"primary":{"URL":"https:\/\/insightsimaging.springeropen.com\/articles\/10.1186\/s13244-025-02122-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1186\/s13244-025-02122-2","relation":{},"ISSN":["1869-4101"],"issn-type":[{"value":"1869-4101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"15 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was carried out according to the Helsinki Declaration. The protocol was approved by the local ethics committee (No. 2022-16427_2, Rhineland-Palatinate, Germany).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Waived by IRB.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"244"}}